Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TXG held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 17.7M | $376.6M | +48.9% | 13.974% | 0.02% |
| 2 | ARK Investment Management LLC | 11.7M | $248.8M | -7.5% | 9.229% | 1.93% |
| 3 | BlackRock, Inc. | 10.1M | $214.0M | +0.7% | 7.940% | 0.00% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.9M | $146.8M | β | 5.445% | 0.01% |
| 5 | Quantinno Capital Management LP | 5.4M | $114.9M | +16.0% | 4.263% | 0.19% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 5.3M | $111.9M | β | 4.151% | 0.00% |
| 7 | Sumitomo Mitsui Trust Holdings, Inc. | 5.1M | $108.5M | -7.0% | 4.025% | 0.07% |
| 8 | Nikko Asset Management Americas, Inc. | 5.1M | $108.3M | -7.0% | 4.020% | 1.53% |
| 9 | GOLDMAN SACHS GROUP INC | 4.1M | $87.2M | +33.1% | 3.237% | 0.01% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $61.7M | +4.1% | 2.288% | 0.00% |
| 11 | MORGAN STANLEY | 2.7M | $56.4M | -16.9% | 2.092% | 0.00% |
| 12 | STATE STREET CORP | 2.6M | $55.0M | +3.0% | 2.039% | 0.00% |
| 13 | AQR CAPITAL MANAGEMENT LLC | 2.5M | $53.7M | -1.6% | 1.999% | 0.02% |
| 14 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.3M | $48.5M | -13.5% | 1.799% | 0.20% |
| 15 | Casdin Capital, LLC | 2.3M | $48.3M | +62.5% | 1.792% | 3.66% |
| 16 | DIMENSIONAL FUND ADVISORS LP | 2.0M | $43.4M | +34.6% | 1.609% | 0.01% |
| 17 | Capital World Investors | 1.5M | $30.8M | 0.0% | 1.144% | 0.00% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1M | $23.9M | +1.9% | 0.888% | 0.00% |
| 19 | Blue Water Life Science Advisors, LLC | 1.1M | $23.1M | β | 0.859% | 18.56% |
| 20 | NORTHERN TRUST CORP | 1.0M | $22.2M | +5.5% | 0.826% | 0.00% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 1.0M | $21.4M | -34.9% | 0.795% | 0.03% |
| 22 | BALYASNY ASSET MANAGEMENT LLC | 990K | $21.0M | β | 0.779% | 0.07% |
| 23 | BANK OF AMERICA CORP /DE/ | 965K | $20.5M | -47.5% | 0.760% | 0.00% |
| 24 | Connor, Clark & Lunn Investment Management Ltd. | 938K | $19.9M | +32.3% | 0.739% | 0.05% |
| 25 | CITADEL ADVISORS LLC | 932K | $19.8M | +275.1% | 0.734% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TXG β a direct measure of their conviction.
Filings activity in TXG during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new TXG position in Q1 2026
Institutions that fully closed their TXG position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 322 | +0.9% | 69.87% | +14.47 pp | $2.56B | +26% |
| Q4 2025 | 319 | +4.2% | 55.40% | +17.06 pp | $2.03B | +45% |
| Q3 2025 | 306 | +4.4% | 38.34% | +0.99 pp | $1.40B | +2.6% |
| Q2 2025 | 293 | +11% | 37.35% | +11.30 pp | $1.37B | +43% |
| Q1 2025 | 264 | 0.8% | 26.05% | 11.45 pp | $954M | 31% |
| Q4 2024 | 266 | +2.7% | 37.50% | 20.21 pp | $1.37B | 35% |
| Q3 2024 | 259 | +1.6% | 57.71% | +5.86 pp | $2.11B | +11% |
| Q2 2024 | 255 | β | 51.85% | β | $1.90B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TXG stock.
Based on Q1 2026 13F filings, institutional ownership of 10x Genomics, Inc. stands at 69.9%, held across 322 reporting institutions.
FMR LLC is the largest reported institutional holder of TXG, with approximately 17,740,972 shares worth $0.38B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of TXG, including ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for TXG is 71 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
55 institutions opened new positions in TXG during Q1 2026, while 52 fully exited. 218 added to existing positions and 47 trimmed.
TXG institutional ownership rose by 14.47 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 61.7% of all reported 13F value in TXG, and the top 25 account for 81.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
10x Genomics, Inc. (TXG) Institutional Ownership